Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9195 |
High Similarity |
NPD4380 |
Phase 2 |
0.9139 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9116 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9085 |
High Similarity |
NPD7075 |
Discontinued |
0.9013 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8966 |
High Similarity |
NPD1549 |
Phase 2 |
0.8947 |
High Similarity |
NPD1934 |
Approved |
0.8897 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8897 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8896 |
High Similarity |
NPD3882 |
Suspended |
0.8859 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8839 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8828 |
High Similarity |
NPD2796 |
Approved |
0.8824 |
High Similarity |
NPD6801 |
Discontinued |
0.8792 |
High Similarity |
NPD6799 |
Approved |
0.8759 |
High Similarity |
NPD1510 |
Phase 2 |
0.8741 |
High Similarity |
NPD1240 |
Approved |
0.871 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8645 |
High Similarity |
NPD2801 |
Approved |
0.8636 |
High Similarity |
NPD7411 |
Suspended |
0.8634 |
High Similarity |
NPD3818 |
Discontinued |
0.8621 |
High Similarity |
NPD1607 |
Approved |
0.8608 |
High Similarity |
NPD5494 |
Approved |
0.858 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD6599 |
Discontinued |
0.8543 |
High Similarity |
NPD1511 |
Approved |
0.8537 |
High Similarity |
NPD6559 |
Discontinued |
0.8526 |
High Similarity |
NPD7819 |
Suspended |
0.8523 |
High Similarity |
NPD2800 |
Approved |
0.8509 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8509 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8509 |
High Similarity |
NPD6166 |
Phase 2 |
0.8431 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8377 |
Intermediate Similarity |
NPD920 |
Approved |
0.8354 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8323 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8303 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8302 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8302 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8282 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8278 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8278 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8258 |
Intermediate Similarity |
NPD5403 |
Approved |
0.825 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8247 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8247 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8247 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8247 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8242 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8235 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8224 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.82 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.82 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8193 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8146 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8144 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8129 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8125 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8105 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8098 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8095 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8086 |
Intermediate Similarity |
NPD919 |
Approved |
0.8049 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8047 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8036 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8024 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.8024 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8013 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7974 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7935 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7892 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7871 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7867 |
Intermediate Similarity |
NPD943 |
Approved |
0.7852 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7824 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7755 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7742 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7733 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7709 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7702 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7688 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7684 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7657 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7632 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7632 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7622 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7619 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7619 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7613 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7613 |
Intermediate Similarity |
NPD6099 |
Approved |
0.76 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7598 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7598 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7582 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7582 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.758 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7564 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7564 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD9717 |
Approved |
0.755 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7544 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD2403 |
Approved |
0.75 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7486 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7468 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7467 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7456 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7453 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7453 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7448 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7442 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.744 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7417 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7414 |
Intermediate Similarity |
NPD3823 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.741 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7401 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7386 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7386 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7375 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7375 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7374 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7365 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7355 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7349 |
Intermediate Similarity |
NPD37 |
Approved |
0.7346 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7342 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7342 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7342 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7342 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7326 |
Intermediate Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7321 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD4965 |
Approved |
0.732 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7315 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7305 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.729 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7285 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7278 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7263 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7246 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7237 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7225 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7209 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7192 |
Intermediate Similarity |
NPD9493 |
Approved |
0.719 |
Intermediate Similarity |
NPD9494 |
Approved |
0.719
|
Intermediate Similarity |
NPD2861 |
Phase 2 |